2'-Hydroxy-5'-methylacetophenone
Common Name: |
2'-Hydroxy-5'-methylacetophenone |
IUPAC Name: |
1-(2-hydroxy-5-methylphenyl)ethanone |
Molecular Formula: |
C9H10O2 |
SMILES: |
CC1=CC(=C(C=C1)O)C(=O)C |
Inchi: |
1S/C9H10O2/c1-6-3-4-9(11)8(5-6)7(2)10/h3-5,11H,1-2H3 |
Inchi Key: |
YNPDFBFVMJNGKZ-UHFFFAOYSA-N |
Cas No: |
1450-72-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
150.17 |
Mass (g/mol) |
150.068 |
Molar Refractivity |
43.63 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
50 |
Boiling Point (°C@760.00mm Hg) |
210 |
Vapor Pressure (mmHg@25.00 °C) |
0.021 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.22 |
LogP |
1.903 |
iLOGP |
1.96 |
XLOGP3 |
2.28 |
WLOGP |
1.90 |
MLOGP |
1.44 |
ESOL Log S |
-2.55 |
ESOL Solubility (mg/ml) |
0.428 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.70 |
Ali Solubility (mg/ml) |
0.3 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.53 |
Silicos-IT Solubility (mg/ml) |
0.45 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.60 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.781 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.18 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |